- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03113630
Virtual Task in Amyotrophic Lateral Sclerosis
Efficacy of Different Interaction Devices Using Virtual Task in Amyotrophic Lateral Sclerosis
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Participants A total of 60 individuals participated in this study, 30 individuals with ALS (18 men and 12 women, mean age 59 years, range 44-74 years) and 30 healthy individuals who formed the control group, which were (equally) matched individually for age and gender with ALS group.
Rating scales For clinical characteristics of the participants, the scales of functional assessment, fatigue and quality of life were applied. As a functional assessment tool, the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS - R) was used, validated in Brazilian individuals with ALS which allows monitoring of symptoms and limitations of daily living activities. To evaluate fatigue during the execution of tasks, were used the Fatigue Severity Scale (FSS) and for the assessment of quality of life, were used the Amyotrophic Lateral Sclerosis Assessment Questionnaire in the Portuguese Language (ALSAQ-40/BR), which is also validated for the Brazilian population with ALS.
Protocol Subjects were randomly divided into three groups, using different interfaces for the acquisition of movement. The description of the task and the RV interfaces that were used are described as follows.
Task Participants performed a task to test communication devices developed by the Information Systems Team at the University of São Paulo. The task was set up as a game in which the goal was to reach as many bubbles displayed on an 11-inch computer monitor, forming seven rows and 18 columns with a total of 126 bubbles. This required individuals to be able to use a range as is typically required in communication systems. The task was divided into two phases: (1) the first phase was characterized by identification of dexterity zone or range of reach, in which the subject had to touch ("burst") the largest possible number of bubbles (changing bubble color from blue to gray) in a set time of 30 seconds, identifying the range zone; (2) the second phase was characterized as the persecution stage, at this time the researcher defined a central bubble (usually chosen in the center of the skill area, on the bottom line), which changed the color to red. From this moment the individual pursued random bubbles that appeared in their range zone, alternating with a return to the central bubble. This phase was carried out for 30 seconds. To motivate, the task randomly provided bubbles outside the range zone and generated a greater challenge to the individual. The software generated information of the coordinates x, y (row and column) where the bubble was touched and the time the bubble was touched. During task execution, the participant received feedback of the number of bubbles touched, the remaining playing time and the total number of points obtained in attempts, thus observing the performance of the participants.
Interfaces To perform the task were used 3 different interfaces: two interfaces without physical contact, being the Kinect® for Windows from Microsoft, composed of a traditional RGB camera and an infrared depth sensor (IR) and LMC®, characterized as a small motion sensor that demonstrated robustness to measure the movements of the hand and fingers. The interface with physical contact, the touchscreen, was the computer screen itself, where individuals touched the screen in order to burst the bubbles, performing the task. It is noteworthy that the touchscreen is a sensitive interface, employed through pressure, created in order to interact with digital information, found in a majority of modern consumer electronics, mainly computers, tablets and mobile phones.
Procedures and design Individuals who participated in the study gave written informed consent and then were sent to a reserved and quiet room to perform the tasks only in the presence of the researcher. The computer monitor was positioned on a table in front of the participants. The chair was adjusted in accordance with the size and need of the individual, with a footrest available if needed. For wheelchair users, their own wheelchair was used. After the necessary adjustments to perform the task, questionnaires and functional assessment scales were applied; then the researcher provided verbal instructions and performed a demonstration of interfaces according to each task (Kinect® for Windows, LMC® or touchscreen). Subjects were instructed to use the dominant hand (i.e., the least affected side) for all interfaces used during the game.
For the acquisition phase a target was set of 300 bubbles to be touched in the definition phase of the dexterity zone. There were 126 bubbles presented during each attempt; therefore it took at least three attempts to reach the proposed goal. Soon after the step establishing the dexterity zone, the researcher defined the central bubble and began the stage of chase area. In addition to the acquisition phase, all groups performed a retention test after 5 minutes with the completion of only one attempt. After the retention test, two transfer tests with the change of interfaces were performed.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Sao Paulo, Brésil, 03828-000
- Escola de Artes,Ciencias e Humanidades da Universidade d Sao Paulo
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- individuals diagnosed with ALS defined according to the revised classification of El Escorial;
- individuals who regularly attended the Neuromuscular Disease Research Sector (SIDNM) of the Federal University of São Paulo
Exclusion Criteria:
- individuals who had other diagnosis of neuromuscular disease such as: progressive muscular atrophy (PMA), progressive bulbar paralysis (PBP), primary lateral sclerosis (PLS);
- individuals associated with other neurodegenerative diseases;
- those presenting established functional disability that would prevent the completion of the task.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Acquisition sur écran tactile
Les sujets pratiquent la tâche et la rétention TouchScreen, transfert 1 sur LeapMotion et transfert 2 sur Kinect
|
Les participants ont effectué l'acquisition et la rétention sur TouchScreen, le transfert 1 sur Kinect et le transfert 2 sur LeapMotion.
|
|
Expérimental: Acquisition sur Kinect
Les sujets pratiquent la tâche et la rétention Kinect, transfert 1 sur TouchScreen et transfert 2 sur LeapMotion.
|
Les participants ont effectué l'acquisition et la rétention sur Kinect, le transfert 1 sur TouchScreen et le transfert 2 sur LeapMotion.
|
|
Expérimental: Acquisition sur LeapMotion
Les sujets pratiquent la tâche et la rétention LeapMotion, transfert 1 sur TouchScreen et transfert 2 sur Kinect.
|
Les participants ont effectué l'acquisition et la rétention sur LeapMotion, le transfert 1 sur TouchScreen et le transfert 2 sur Kinect.
|
|
Comparateur actif: Acquisition sur TouchScreen Control Group
Les sujets pratiquent la tâche et la rétention TouchScreen, transfert 1 sur LeapMotion et transfert 2 sur Kinect
|
Participants performed acquisition and retention on TouchScreen, transfer 1 on Kinect and transfer 2 on LeapMotion.
|
|
Comparateur actif: Acquisition sur Kinect Control Group
Les sujets pratiquent la tâche et la rétention Kinect, transfert 1 sur TouchScreen et transfert 2 sur LeapMotion.
|
Participants performed acquisition and retention on Kinect, transfer 1 on TouchScreen and transfer 2 on LeapMotion.
|
|
Comparateur actif: Acquisition sur LeapMotion Control Group
Les sujets pratiquent la tâche et la rétention LeapMotion, transfert 1 sur TouchScreen et transfert 2 sur Kinect.
|
Participants performed acquisition and retention on LeapMotion, transfer 1 on TouchScreen and transfer 2 on Kinect.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Motor performance improvement in a virtual Timing Coincident task, comparing performance between LeapMotion, TouchScreen and Kinect.
Délai: 3 months
|
Analysis of the motor performance using a virtual Coincident timing task in different devices to compare wether a task with or without contact promote better performance for people with Amyotrophic Lateral Sclerosis
|
3 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Carlos BM Monteiro, Ph.D., University of Sao Paulo
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Processus pathologiques
- Maladies métaboliques
- Maladies du système nerveux central
- Maladies du système nerveux
- Maladies neuromusculaires
- Maladies neurodégénératives
- Maladies de la moelle épinière
- TDP-43 Protéinopathies
- Déficits de protéostase
- Sclérose
- Maladie du motoneurone
- La sclérose latérale amyotrophique
Autres numéros d'identification d'étude
- 105/15
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Acquisition sur écran tactile
-
Gansu Provincial Maternal and Child Health Care...RecrutementDéficience cognitive | Étude de cohorte | Diabète sucré gestationnel pendant la grossesseChine
-
SpinTech, Inc.University of Iowa; University of Texas Southwestern Medical Center; Loma Linda... et autres collaborateursComplété
-
Cairo UniversityPas encore de recrutementErreurs de procédure endodontique dans les dents traitées au canal radiculaire
-
University of AlbertaAlberta Health services; MitacsPas encore de recrutementAccident vasculaire cérébral | Lésion cérébrale traumatique | Lésion cérébrale acquiseCanada
-
Radius Pharmaceuticals, Inc.RésiliéSyndrome de Prader WilliÉtats-Unis
-
Northwell HealthActif, ne recrute pasPrévention du déconditionnement acquis de l'hôpital chez les patients hospitalisés de leucémie aiguëLeucémie aiguëÉtats-Unis
-
Stanford UniversityComplétéLe syndrome de MarfanÉtats-Unis
-
Harmony Biosciences Management, Inc.Zynerba Pharmaceuticals, Inc.ComplétéSyndrome de délétion 22q11.2États-Unis, Australie
-
Jena University HospitalGE HealthcareInconnueMaladies thyroïdiennes | Nodule thyroïdien | Goitre thyroïdienAllemagne
-
Brigham and Women's HospitalComplétéTrouble lié à l'utilisation d'opioïdesÉtats-Unis